Dr. Will C. Eward

As an orthopaedic oncologist, I am passionate about providing the best diagnostic and therapeutic surgical care for patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. As the director of the Sarcoma program at the Duke Cancer Institute, my passion is building our team to provide the best clinical care and basic scientific, translational and clinical research to serve our patients. Dr. Brigman is rated as an Elite provider by MediFind in the treatment of Desmoid Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Bone Graft, and Hip Replacement.

I am an orthopaedic oncologist and specialize in tumors that affect bone and soft tissue in the musculoskeletal system. I was introduced to this specialty by my mentor in medical school, who taught me how truly complex the biology of bone is and how it contributes to human disease. I enjoy finding surgical solutions to treat tumors, and I always try to understand what the tumor does to the body, how the body reacts to the tumor, and how the tumor evolves in response to its environment. This is the driving force behind much of my research. My patients motivate me to find innovative solutions to treat their disease. Every person is different, and it is my job to understand who you are and what your goals are in order to work with you to come up with the best possible treatment plan. Dr. Visgauss is rated as an Advanced provider by MediFind in the treatment of Desmoid Tumor. Her top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Liposarcoma, Bone Graft, and Hip Replacement.

I’m a fellowship-trained surgical oncologist who specializes in the surgical management of patients with gastrointestinal malignancies—including soft tissue sarcomas and pancreas, colorectal and gastric cancers. Many of my patients have advanced malignancies and I am always amazed at their resilience. Their determination to fight inspires me to aggressively pursue every surgical option and to study novel techniques to improve surgical outcomes. One of the most important reasons for patients to be treated at Duke is the emphasis on a team-oriented approach to every patient. Nearly every surgical cancer patient is discussed in a multidisciplinary tumor conference in order to assure state of the art care. When I am not in the hospital, my wife and I can be found chasing our two young children or running with our dog. Dr. Blazer-Iii is rated as a Distinguished provider by MediFind in the treatment of Desmoid Tumor. His top areas of expertise are Retroperitoneal Liposarcoma, Desmoplastic Small Round Cell Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.